A comprehensive meta-analysis reported that the overexpression of STAT3 was correlated with low disease-free survival and poor prognosis of the stomach, lung, brain, liver, bone, prostate, and pancreas cancers (Wu et al., 2016). The gene discussed is STAT3; the disease is pancreatic neoplasm.